Archive for the ‘IVD’ Category
Monday, November 19th, 2012
In an effort to bring uniformity to India's IVD sector, the Drug Controller General of India (DCGI) plans to issue guidance for the regulation of in vitro diagnostic devices and reagents. The initiative was announced following a request for guidance by industry at a recent meeting with DCGI, reports Pharmabiz.com.
Posted in Filtration, IVD, Packaging | Add Comment »
Thursday, May 17th, 2012
Have you heard of Chindia? I’ll give you a clue: it’s BRICs adjacent.
In a recent article in IVD Technology, Carl McEvoy, Partner at McEvoy & Farmer (Seattle, WA, USA), a market research firm focussed on the IVD industry, compares the IVD markets of China and India, or Chindia as some ...
Posted in IVD | Add Comment »
Tuesday, February 21st, 2012
The trend of placing high-end analysers under reagent rental schemes is gaining momentum in India. It is expected to be the prime factor driving the growth of India's biochemistry instruments and reagents market.
Posted in IVD, Uncategorized | Add Comment »
Friday, December 16th, 2011
The International Conference on Technological Challenges in Developing Affordable In-Vitro Molecular Diagnostics will be held from 11 to 14 March 2012 in Navi Mumbai, India. The conference aims to assess the needs and priorities in the area of IVDs and identify major hurdles in developing novel, rapid and indigenous cost-effective ...
Posted in IVD, Uncategorized | Add Comment »
Wednesday, November 23rd, 2011
India accounts for almost a quarter of tuberculosis cases and 25% of multidrug resistant (MDR) cases in the world, yet there has not been any attempt to produce an innovative diagnostic test for TB on the subcontinent.
The diagnostic test that is currently used by the Indian TB programme (RNTCP) for ...
Posted in IVD, Uncategorized | Add Comment »
Tuesday, March 29th, 2011
As part of a strategic seven-year deal with Siemens Healthcare Diagnostics, Thyrocare Technologies Ltd will soon boast a state-of-the-art lab automation system from Siemens that will help reduce turnaround times for testing samples by three hours. The new technology is expected to be operational by 1 May 2011.
Posted in IVD, medical device OEMs | Add Comment »
Friday, February 11th, 2011
ERBA Diagnostics Mannheim GmbH, a wholly owned subsidiary of Transasia Bio-Medicals Ltd India, recently acquired a 100% stake in Diasis Diagnostik Sistemler Ticaret Ve Sanayi A.S.
Posted in IVD | Add Comment »
